XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Prior Financial Information (Tables)
12 Months Ended
Dec. 31, 2022
Prior Period Adjustment [Abstract]  
Summary of effect of the error corrections

The effect of the error corrections are as follows (in thousands, except per share amounts):

 

December 31, 

December 31, 

    

2022

    

2022

CONSOLIDATED BALANCE SHEETS

As previously reported

Adjustments

As Restated

ASSETS

Non-current deposits

$

2,916

$

549

$

3,465

Total assets

$

27,501

$

549

$

28,050

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

  

Accrued and other current liabilities

$

4,831

$

119

$

4,950

Total current liabilities

 

7,392

 

119

7,511

Total liabilities

$

7,498

$

119

$

7,617

Accumulated deficit

 

(406,157)

 

430

(405,727)

Total stockholders’ equity

 

15,509

 

430

15,939

Total liabilities and stockholders’ equity

$

27,501

$

549

$

28,050

 

Year Ended December 31,

2022

    

2022

CONSOLIDATED STATEMENTS OF INCOME

    

As previously reported

Adjustments

As Restated

Net loss applicable to common shareholders

$

(21,399)

$

$

(21,399)

Basic and diluted earnings per common share:

Net Loss per share - basic and diluted (common shareholders)

$

(1.90)

$

(0.01)

$

(1.91)

Net Loss per share - basic and diluted (redeemable common shareholders)

$

$

(1.82)

$

(1.82)

 

Year Ended December 31,

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

    

2022

    

2022

As previously reported

Adjustments

As Restated

Accumulated Deficit (Balances at December 31, 2022)

$

(406,157)

$

430

$

(405,727)

Total Stockholders' Equity (Balances at December 31, 2022)

$

15,509

$

430

$

15,939

 

December 31, 

December 31, 

    

2021

    

2021

CONSOLIDATED BALANCE SHEETS

As previously reported

Adjustments

As Restated

ASSETS

Non-current deposits

$

1,551

$

549

$

2,100

Total assets

$

42,587

$

549

$

43,136

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

  

Accrued and other current liabilities

$

3,177

$

119

$

3,296

Total current liabilities

 

5,294

 

119

5,413

Total liabilities

$

5,324

$

119

$

5,443

Accumulated deficit

 

(384,959)

 

430

(384,529)

Total stockholders’ equity

 

37,263

 

430

37,693

Total liabilities and stockholders’ equity

$

42,587

$

549

$

43,136

 

Year Ended December 31,

2021

    

2021

CONSOLIDATED STATEMENTS OF INCOME

    

As previously reported

Adjustments

As Restated

Operating expenses:

 

Research and development

$

15,477

$

(549)

$

14,928

Total operating expenses

 

22,938

 

(549)

22,389

Operating loss

 

(22,938)

 

549

(22,389)

Loss before taxes

 

(22,734)

 

549

(22,185)

Income tax benefit

 

3,847

 

(119)

3,728

Net loss

 

(18,887)

 

430

(18,457)

Net loss applicable to common shareholders

$

(19,088)

$

430

$

(18,658)

Basic and diluted earnings per common share:

 

  

 

  

 

Net loss per share – basic and diluted

$

(2.14)

$

0.05

$

(2.09)

 

Year Ended December 31,

    

2021

    

2021

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

As previously reported

Adjustments

As Restated

Net loss

$

(18,887)

$

430

$

(18,457)

Comprehensive loss

$

(18,887)

$

430

$

(18,457)

 

Year Ended December 31,

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

    

2021

    

2021

As previously reported

Adjustments

As Restated

Accumulated Deficit (Loss for the period)

$

(18,887)

$

430

$

(18,457)

Accumulated Deficit (Balances at December 31, 2021)

$

(384,959)

$

430

$

(384,529)

Total Stockholders' Equity (Balances at December 31, 2021)

$

37,263

$

430

$

37,693

 

Year Ended December 31,

    

2021

    

2021

CONSOLIDATED STATEMENTS OF CASH FLOWS

As previously reported

Adjustments

As Restated

Operating activities:

Net loss

$

(18,887)

$

430

$

(18,457)

Changes in operating assets and liabilities:

 

 

 

Prepaid expenses and other assets

(3,931)

(549)

(4,480)

Accounts payable, accrued and other current liabilities

2,906

119

3,025